Harnessing the Power of microRNAs: Implications for Cancer Development and Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 218
Special Issue Editor
Interests: microRNA; andro-miRs; androgen receptor; non-coding RNAs; nuclear precursor mRNA processing; snRNA; RNA–-RNA interactions; RNA–-protein interactions
Special Issue Information
Dear Colleagues,
MicroRNAs (miRNAs) are small, regulatory, non-coding RNAs that are pivotal in governing gene expression at the post-transcriptional level. The fine-tuned control of gene expression by miRNAs is fundamental to nearly all biological processes. Consequently, when fine-tuned regulation goes awry, it contributes significantly to the development and progression of numerous diseases, including cancers. Understanding the intricate web of regulatory interactions involving miRNAs opens a vast reservoir of potential therapeutic targets.
The primary goal of this Special Issue is to assemble original primary research papers and comprehensive reviews that examine the recent developments in miRNAs, covering their functions in both health and disease contexts. We are interested in recent advances in understanding the molecular mechanisms underlying miRNA actions, shedding light on their roles in typical physiological processes and diseases. We welcome contributions centered on identifying therapeutic targets associated with miRNAs, innovative approaches to RNA-based therapies involving miRNAs, their pioneering delivery methods, the biomarker potential of miRNAs found in tissue, cell and body fluids, the exploration of the role of miRNAs in tumor metabolism, tumor-promoting inflammation, proliferative signaling, dysregulation of cellular metabolism and angiogenesis, cell cycle regulation, epithelial to mesenchymal transition, cellular invasion, and maintenance of the tumor microenvironment.
Prof. Dr. Girish Shukla
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor microenvironment
- cancer cell metabolism
- tumor-promoting inflammation
- epithelial to mesenchymal transition
- miRNA and cancers
- miRNA biomarkers
